header
August 12, 2019

In This Issue
IN THE SPOTLIGHT
MMA's 166th Annual Session in Bar Harbor September 6-8
Surprise Billing Legislation Being Considered in Congress
Proposed Medicare Fee Schedule Changes
Recent Study Suggests CV Risk Reduction From Continuing Statins After 75
This Week's Public Health Updates from the AMA
10th Annual Silent Auction to Be Held at Annual Session
MICIS Individual Academic Detailing Sessions on Opioid Topics
United States Census 2020
129th MAINE LEGISLATURE
MMA Legislative Calls Finished for the Session
UPCOMING EVENTS
Upcoming Specialty Society Meetings
Complex Mental and Behavioral Health Needs of Maine Youth - August 16
Quality Counts: Rapid Induction Starting in the ED (RISE) Training, ECHO Program
Obesity Medicine: There is no 'one size fits all' - Monthly Lecture Series Beginning September 18th
Maine Concussion Management Initiative (MCMI) Training Program - October 9
MMA partners with the Maine Suicide Prevention Program to offer training for clinicians.
HEALTHCARE EMPLOYMENT OPPORTUNITIES
Outpatient Internal Medicine Physician Bangor, Maine
BC/BE Family Medicine or Internal Medicine Physician
Northern Light Sebasticook Valley Hospital seeks a BC/BE General Surgeon
Family Medicine Opportunity in Beautiful Western Maine
Physician Director of Primary Care
Family Medicine Specialist or an Internist
VOLUNTEER OPPORTUNITIES
Opportunities at the VA for Volunteer Physicians
Volunteer Opportunity with Partners for World Health

 
Search Back Issues



 

 

 

 


Follow Us:
Recent Study Suggests CV Risk Reduction From Continuing Statins After 75

A recent European study suggests potential cardiovascular risk reduction associated with continuing statin therapy after the age of 75 years in persons already taking these drugs for primary prevention. However, due to the observational nature of this study, residual confounding cannot be excluded. Future studies, including interventional randomized studies, are needed to confirm these findings and support updating and clarification of guidelines on the use of statins for primary prevention in the elderly.

The role of statin therapy in primary prevention of cardiovascular disease in persons older than 75 years remains a subject of debate with little evidence to support or exclude the benefit of this treatment. The researchers assessed the effect of statin discontinuation on cardiovascular outcomes in previously adherent 75-year-olds treated for primary prevention. The study itself may be read here: https://academic.oup.com/eurheartj/advance-article/doi/10.1093/eurheartj/ehz458/5540819

< Previous Article | Next Article >

[ return to top ]

To ensure delivery of Maine Medicine Weekly Update,
please add 'info@mainemed.com' to your email address book or Safe Sender List.
If you are still having problems receiving our communications,
see our white-listing page for more details: http://www.commpartners.com/website/white-listing.htm


Unsubscribe here

For more information or to contact us directly, please visit www.mainemed.com | ©